[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:aplastic-anemia":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":129,"states":134},"Aplastic Anemia",19,14,[8,16,22,28,34,40,46,53,60,66,72,78,84,90,96,103,110,117,123],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06430788","A Study of Emapalumab for Pediatric Aplastic Anemia",[12],"Phase 2","RECRUITING","2026-08-26T02:17:00.709807Z","2026-05-05T02:43:29.298110Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT04558736","Haploidentical HCT for Severe Aplastic Anemia",[12],"2026-08-26T02:16:36.513735Z","2026-05-05T02:43:28.475639Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT01624805","Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and\u002For Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome",[12],"2026-08-26T02:17:47.813245Z","2026-05-05T02:43:28.419128Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT02828592","Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia",[12],"2026-08-26T02:19:13.549512Z","2026-05-05T02:43:26.674514Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT05194397","Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors",[12],"2026-08-26T02:16:03.788292Z","2026-05-05T02:43:28.669280Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":44,"content_modified":45},"NCT05031897","Two Step Haplo With Radiation Conditioning",[12],"2026-08-26T02:16:32.589113Z","2026-05-05T02:43:29.158573Z",{"nct_id":47,"title":48,"phases":49,"status":13,"updated_at":51,"content_modified":52},"NCT06839456","Phase 1\u002F2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab\u002FCD19 Depleted HSCT",[50],"Phase 1\u002FPhase 2","2026-08-26T02:18:26.932189Z","2026-05-05T02:43:28.655842Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":58,"content_modified":59},"NCT06398457","Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies",[57],"Early Phase 1","2026-08-26T02:15:53.461103Z","2026-05-05T02:43:27.839395Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT07227155","The HOPE Biobank Resource (BMT CTN 2402 HOPE)",[],"2026-08-26T02:15:15.642947Z","2026-06-17T02:29:30.055580Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT05012111","Natural History of Acquired and Inherited Bone Marrow Failure Syndromes",[],"2026-08-26T02:16:14.341106Z","2026-05-13T02:55:06.278944Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT03016806","Umbilical Cord Blood Transplantation From Unrelated Donors",[],"2026-08-26T02:15:21.365312Z","2026-05-13T02:55:06.119599Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT01137643","Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer",[],"2026-08-26T02:16:58.658552Z","2026-05-13T02:55:06.068895Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT04764357","Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors",[],"2026-08-26T02:17:11.311767Z","2026-05-05T02:43:29.491681Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT06689800","Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy",[],"2026-08-26T02:19:29.119921Z","2026-05-05T02:43:28.852930Z",{"nct_id":97,"title":98,"phases":99,"status":100,"updated_at":101,"content_modified":102},"NCT07001254","UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia",[12],"NOT_YET_RECRUITING","2026-08-26T02:15:24.145250Z","2026-05-05T02:43:27.611755Z",{"nct_id":104,"title":105,"phases":106,"status":107,"updated_at":108,"content_modified":109},"NCT07102849","Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study",[],"ENROLLING_BY_INVITATION","2026-08-26T02:15:41.377360Z","2026-06-16T05:54:07.855055Z",{"nct_id":111,"title":112,"phases":113,"status":114,"updated_at":115,"content_modified":116},"NCT02928991","Fludarabine Based RIC for Bone Marrow Failure Syndromes",[57],"ACTIVE_NOT_RECRUITING","2026-08-03T03:20:26.944531Z","2026-05-05T02:43:27.804340Z",{"nct_id":118,"title":119,"phases":120,"status":114,"updated_at":121,"content_modified":122},"NCT06752694","Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia",[12],"2026-08-03T02:10:11.726086Z","2026-05-05T02:35:31.677412Z",{"nct_id":124,"title":125,"phases":126,"status":114,"updated_at":127,"content_modified":128},"NCT05998408","JAK1\u002F2 Inhibitor Ruxolitinib for Relapsed\u002FRefractory Immune Bone Marrow Failure",[50],"2026-08-03T02:04:34.624671Z","2026-05-05T02:35:31.872333Z",[130],{"biomarker":131,"count":132,"slug":133},"HLA Complex",3,"hla-complex",[135,139,143],{"state":136,"count":137,"slug":138},"Pennsylvania",5,"pennsylvania",{"state":140,"count":141,"slug":142},"Maryland",4,"maryland",{"state":144,"count":141,"slug":145},"Tennessee","tennessee"]